Potential of gut microbiota metabolites in treating COPD: network pharmacology and Mendelian randomization approaches

Potential of gut microbiota metabolites in treating COPD: network pharmacology and Mendelian randomization approaches

ObjectiveThe gut microbiota and its metabolites exert a significant influence on COPD, yet the underlying mechanisms remain elusive. We aim to holistically evaluate the role and mechanisms of the gut microbiota and its metabolites in COPD through network pharmacology and Mendelian randomization appr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhenghua Cao, Shengkun Zhao, Tong Wu, Feng Sun, Shaodan Hu, Li Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Microbiology
Subjects:	network pharmacology MR COPD biological network Phenylacetylglutamine
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1416651/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology
by: Hao-Ming Zhou, et al.
Published: (2024-12-01)

Protective effect of Shenqi Wenfei Formula against lipopolysaccharide/cigarette smoke-induced COPD in Rat based on gut microbiota and network pharmacology analysis
by: Mengyao Shi, et al.
Published: (2024-11-01)

Elucidating the role of gut microbiota metabolites in diabetes by employing network pharmacology
by: Weiguo Yao, et al.
Published: (2024-12-01)

Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Tyler Pitre, et al.
Published: (2025-01-01)

Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study
by: Xuan Xu, et al.
Published: (2025-01-01)

The association of gut microbiota, immunocyte dynamics, and protein–protein ratios with tuberculosis susceptibility: a Mendelian randomization analysis
by: Hanxin Wu, et al.
Published: (2025-01-01)

Exploring the causal role of plasma metabolites and metabolite ratios in prostate cancer: a two-sample Mendelian randomization study
by: Changzhou Feng, et al.
Published: (2025-01-01)

Exploring the active components and mechanism of Ziziphi Spinosae Semen in treating insomnia by network pharmacology and metabonomics
by: Xia Yu, et al.
Published: (2025-09-01)

An integrated investigation of mitochondrial genes in COPD reveals the causal effect of NDUFS2 by regulating pulmonary macrophages
by: Xiaoli Zou, et al.
Published: (2025-01-01)

Network pharmacology: a crucial approach in traditional Chinese medicine research
by: Yiyan Zhai, et al.
Published: (2025-01-01)

A network pharmacology study on the main active constituents and key pharmacological pathways of Shaoyao Gancao decoction on Osteoarthritis
by: Qiuyue LI, et al.
Published: (2021-03-01)

COPD-ES Questionnaire Based COPD Patients Management in Stable Phrase Improves Disease Group Classification
by: Yang Y, et al.
Published: (2024-12-01)

Editorial: Systems pharmacology in the spotlight: trending technologies in network biology and drug discovery
by: Raghuveera Kumar Goel, et al.
Published: (2024-12-01)

Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?
by: Alan G. Kaplan
Published: (2024-11-01)

Identification of the Role of Mume fructus in Treating Nocturnal Asthma Based on Network Pharmacology and In vitro Investigation
by: Ling-Ling Tang, et al.
Published: (2024-12-01)

COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01)

COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)

Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
by: Zhaohui Gong, et al.
Published: (2025-01-01)

Pharmacological potential of Portulacaria afra: A review on bioactive compounds, pharmacological uses and therapeutic prospects
by: Yvonne Mhosva, et al.
Published: (2024-12-01)

COPD in females- Seeing through the smoke
by: S R Sreedevi, et al.
Published: (2025-01-01)

Analysis of the Potential Mechanism of Sanhua Decoction in Treating Ischemic Stroke Based on Network Pharmacology and Molecular Docking Technology
by: Wei Zhao, et al.
Published: (2024-12-01)

Editorial: Commercialization and industrialization in experimental pharmacology and drug discovery: 2023
by: Sirajudheen Anwar, et al.
Published: (2024-12-01)

Analysis of the mechanism of Erchen decoction in treating chronic bronchitis based on network pharmacology and molecular docking
by: Yanshan HE, et al.
Published: (2021-06-01)

Assessment of functional tests on determining resistance of respiratory tract in patients with bronchial asthma, COPD and their combination.
by: K. V. Nazarenko, et al.
Published: (2017-10-01)

Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review
by: Paul Jones, et al.
Published: (2024-12-01)

Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET
by: Alter P, et al.
Published: (2024-12-01)

Network pharmacology, experimental validation and pharmacokinetics integrated strategy to reveal pharmacological mechanism of goutengsan on methamphetamine dependence
by: Han-Cheng Li, et al.
Published: (2024-11-01)

Associations of human blood metabolome with optic neurodegenerative diseases: a bi-directionally systematic mendelian randomization study
by: Bin Tong, et al.
Published: (2024-11-01)

Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
by: Jia Lv, et al.
Published: (2025-02-01)

Network pharmacology and experimental verification reveal the mechanism of Qingfei Tongluo mixture in treating pulmonary fibrosis
by: Ying Zhou, et al.
Published: (2025-01-01)

Network pharmacology and experimental study of Angelica sinensis and Astragalus membranaceus capsules in treating heart failure
by: Xue Wu, et al.
Published: (2024-10-01)

Investigating disturbances of the core material system in the lung-gut axis of COPD based on the transcriptomics-metabolomics-microbiomics integration strategy
by: Tianyang Wang, et al.
Published: (2025-01-01)

Establishing network pharmacology between natural polyphenols and Alzheimer’s disease using bioinformatic tools – An advancement in Alzheimer’s research
by: Arunkumar Subramanian, et al.
Published: (2024-12-01)

Deciphering the pharmacological mechanism of Radix astragali for allergic rhinitis through network pharmacology and experimental validation
by: Yiwei Hua, et al.
Published: (2024-12-01)

COPD exacerbation: anthropometric characteristics of patients and the frequency of hospital admissions
by: Gashynova K.Y.
Published: (2014-11-01)

Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients
by: David Dora, et al.
Published: (2024-11-01)

7-hydroxycoumarin ameliorates ulcerative colitis in mice by inhibiting the MAPK pathway and alleviating gut microbiota dysbiosis
by: Mengqi Liu, et al.
Published: (2024-11-01)

The Role of Bioactive Small Molecules in COPD Pathogenesis
by: Sha Liao, et al.
Published: (2024-12-01)

Multi-target mechanism of polyherbal extract to treat diabetic foot ulcer based on network pharmacology and molecular docking
by: Happy Elda Murdiana, et al.
Published: (2024-04-01)

Network-based pharmacological examination of the potential effector mechanisms of Achyranthes bidentata on osteoarthritis treatment
by: Junfeng WANG, et al.
Published: (2020-12-01)